Steward Partners Investment Advisory’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-22
| Closed | -$51 | – | 3683 |
|
|
2023
Q4 | $51 | Hold |
22
| – | – | ﹤0.01% | 3460 |
|
|
2023
Q3 | $89 | Hold |
22
| – | – | ﹤0.01% | 3321 |
|
|
2023
Q2 | $90 | Hold |
22
| – | – | ﹤0.01% | 3272 |
|
|
2023
Q1 | $68 | Sell |
22
-13
| -37% | -$40 | ﹤0.01% | 3264 |
|
|
2022
Q4 | $95 | Sell |
35
-25
| -42% | -$68 | ﹤0.01% | 3297 |
|
|
2022
Q3 | $0 | Hold |
60
| – | – | ﹤0.01% | 3398 |
|
|
2022
Q2 | $0 | Hold |
60
| – | – | ﹤0.01% | 3384 |
|
|
2022
Q1 | $1K | Sell |
60
-50
| -45% | -$833 | ﹤0.01% | 3230 |
|
|
2021
Q4 | $2K | Sell |
110
-100
| -48% | -$1.82K | ﹤0.01% | 3039 |
|
|
2021
Q3 | $5K | Hold |
210
| – | – | ﹤0.01% | 2825 |
|
|
2021
Q2 | $13K | Sell |
210
-182
| -46% | -$11.3K | ﹤0.01% | 5669 |
|
|
2021
Q1 | $48.3K | Buy |
392
+152
| +63% | +$18.7K | ﹤0.01% | 2003 |
|
|
2020
Q4 | $27K | Sell |
240
-72
| -23% | -$8.1K | ﹤0.01% | 1958 |
|
|
2020
Q3 | $37K | Sell |
312
-50
| -14% | -$5.93K | ﹤0.01% | 1641 |
|
|
2020
Q2 | $45K | Buy |
362
+195
| +117% | +$24.2K | ﹤0.01% | 1461 |
|
|
2020
Q1 | $32K | Buy |
+167
| New | +$32K | ﹤0.01% | 1436 |
|